Is ICSI Risky?

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3600334)

Published in Obstet Gynecol Int on February 26, 2013

Authors

May Y W Wong1, William L Ledger

Author Affiliations

1: School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Randwick, NSW 2031, Australia.

Articles cited by this

Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet (1992) 7.59

The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med (2002) 6.56

Reproductive technologies and the risk of birth defects. N Engl J Med (2012) 4.95

Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. N Engl J Med (2004) 3.86

Assisted reproductive technologies and the risk of birth defects--a systematic review. Hum Reprod (2004) 2.81

Assisted reproductive technology may increase clinical mutation detection in male offspring. Fertil Steril (2008) 2.76

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod (2009) 2.55

Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod (2006) 2.36

Sperm chromatin damage impairs human fertility. The Danish First Pregnancy Planner Study Team. Fertil Steril (2000) 2.30

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States. Fertil Steril (2002) 2.09

Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod (2010) 2.04

Attitudes to clinical andrology: a time for change. Hum Reprod (1997) 2.04

Oxidative stress, DNA damage and the Y chromosome. Reproduction (2001) 1.84

Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation. BMJ (1997) 1.81

Outcome of assisted reproduction. Lancet (2007) 1.72

Randomized single versus double embryo transfer: obstetric and paediatric outcome and a cost-effectiveness analysis. Hum Reprod (2005) 1.67

Should ICSI be the treatment of choice for all cases of in-vitro conception? No, not in light of the scientific data. Hum Reprod (2002) 1.64

The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod (1995) 1.62

A review of ten years experience of ICSI. Hum Reprod Update (2004) 1.60

Relation of mammalian sperm chromatin heterogeneity to fertility. Science (1980) 1.49

Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod (2002) 1.46

Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril (2012) 1.43

Influence of deoxyribonucleic acid damage on fertilization and pregnancy. Fertil Steril (2004) 1.40

A comparison of baseline and induced DNA damage in human spermatozoa from fertile and infertile men, using a modified comet assay. Mol Hum Reprod (1996) 1.38

Late, but not early, paternal effect on human embryo development is related to sperm DNA fragmentation. Hum Reprod (2004) 1.38

Incidence of congenital malformations in children born after ICSI. Hum Reprod (2000) 1.36

Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data. Hum Reprod (2009) 1.36

Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int J Androl (2008) 1.31

A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum Reprod (2004) 1.28

In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods. Birth Defects Res A Clin Mol Teratol (2005) 1.25

Trends in the use of intracytoplasmatic sperm injection marked variability between countries. Hum Reprod Update (2008) 1.24

Congenital malformations in infants born after in vitro fertilization in Sweden. Birth Defects Res A Clin Mol Teratol (2010) 1.15

Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med (2009) 1.14

Sperm chromatin structure assay as an independent predictor of fertility in vivo: a case-control study. Int J Androl (2009) 1.14

Potential significance of genomic imprinting defects for reproduction and assisted reproductive technology. Hum Reprod Update (2004) 1.12

Birth defects in children conceived by ICSI compared with children conceived by other IVF-methods; a meta-analysis. Int J Epidemiol (2004) 1.11

Mammalian sperm DNA susceptibility to in situ denaturation associated with the presence of DNA strand breaks as measured by the terminal deoxynucleotidyl transferase assay. J Androl (1995) 1.10

Assessment of DNA integrity and morphology of ejaculated spermatozoa from fertile and infertile men before and after cryopreservation. Hum Reprod (2001) 1.07

Value of DNA integrity assays for fertility evaluation. Soc Reprod Fertil Suppl (2007) 1.04

Intracytoplasmic sperm injection: achievement of high pregnancy rates in couples with severe male factor infertility is dependent primarily upon female and not male factors. Fertil Steril (1995) 1.03

Male infertility: a risk factor for testicular cancer. Nat Rev Urol (2009) 1.02

The use of the acridine orange test and the TUNEL assay to assess the integrity of freeze-dried bovine spermatozoa DNA. Genet Mol Res (2007) 0.92

An update of assisted reproductive technologies results in the United States. Ann N Y Acad Sci (2008) 0.92

Chromosome abnormalities and Yq microdeletions in infertile italian couples referred for assisted reproductive technique. Sex Dev (2008) 0.91

Growth of children conceived by IVF and ICSI up to 12years of age. Reprod Biomed Online (2009) 0.86

Susceptibility of human sperm to in situ DNA denaturation is strongly correlated with DNA strand breaks identified by single-cell electrophoresis. Exp Cell Res (1997) 0.86

Reduced serum testosterone levels in infant boys conceived by intracytoplasmic sperm injection. J Clin Endocrinol Metab (2007) 0.85

Assisted reproduction technology and defects of genomic imprinting. BJOG (2005) 0.85

Neuromotor development and mental health at 5.5 years of age of singletons born at term after intracytoplasmatic sperm injection ICSI: results of a prospective controlled single-blinded study in Germany. Fertil Steril (2008) 0.84

Safety issues in assisted reproduction technology: should ICSI patients have genetic testing before treatment? A practical proposition to help patient information. Hum Reprod (2004) 0.84

Cost--effectiveness analysis of salpingectomy prior to IVF, based on a randomized controlled trial. Hum Reprod (2005) 0.83

Place of intracytoplasmic sperm injection in management of male infertility. Lancet (2001) 0.83

Genetic considerations related to intracytoplasmic sperm injection (ICSI). Fertil Steril (2006) 0.82

Physical health at 5.5 years of age of term-born singletons after intracytoplasmic sperm injection: results of a prospective, controlled, single-blinded study. Fertil Steril (2008) 0.82

An algorithm to predict pregnancy in assisted reproduction. Hum Reprod (2004) 0.80

Sperm chromosomes and habitual abortion. Fertil Steril (1991) 0.79

Articles by these authors

Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril (2008) 1.75

Peritoneal fluid concentrations of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta in women with pelvic adhesions. Fertil Steril (2003) 1.44

Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril (2009) 1.01

Acupuncture and assisted conception. Cochrane Database Syst Rev (2008) 0.97

Surgical intervention in infertility management. Hum Fertil (Camb) (2003) 0.97

Single-dose pharmacokinetic study of clomiphene citrate isomers in anovular patients with polycystic ovary disease. J Clin Pharmacol (2008) 0.89

Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes (2010) 0.89

Acupuncture and assisted reproductive technology. Cochrane Database Syst Rev (2013) 0.88

Reproductive endocrinology and clinical aspects of obesity in women. Ann N Y Acad Sci (2008) 0.86

Prediction of preeclampsia: can it be achieved? Obstet Gynecol Surv (2004) 0.85

Health-related quality of life among adolescents with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs (2012) 0.83

Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril (2005) 0.82

Evaluation of an existing nomogram for predicting the response to clomiphene citrate. Fertil Steril (2006) 0.80

Long-term complications of assisted reproductive technologies. Hum Fertil (Camb) (2011) 0.80

GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future. Womens Health (Lond Engl) (2014) 0.79

Monitoring plasma concentrations to individualize treatment with clomiphene citrate. Fertil Steril (2004) 0.78

Tissue immunoexpression and messenger ribonucleic acid localization of inhibin/activin subunit in human epididymis. Fertil Steril (2005) 0.78

A study of luteal phase expression of inhibin, activin, and follistatin subunits in the endometrium of women with recurrent miscarriage. Fertil Steril (2006) 0.78

Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome. Womens Health (Lond Engl) (2012) 0.77

Hormones and dichotic listening: evidence from the study of menstrual cycle effects. Brain Cogn (2011) 0.77

Absence of follicular phase defect in women with recurrent miscarriage. Fertil Steril (2006) 0.77

Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology. Womens Health (Lond Engl) (2012) 0.76

Measurement of inhibin A and inhibin pro-alphaC in early human pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent pregnancy loss. Fertil Steril (2003) 0.76

The effects of a third generation combined oral contraceptive pill on the classical singing voice. J Voice (2006) 0.76

GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates. Aust N Z J Obstet Gynaecol (2014) 0.76

Evaluation of the relationship between plasma concentrations of en- and zuclomiphene and induction of ovulation in anovulatory women being treated with clomiphene citrate. Fertil Steril (2008) 0.75

Implications of an irreversible procedure. Fertil Steril (2004) 0.75

Supine positioning after intrauterine insemination. BMJ (2009) 0.75

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles? J Assist Reprod Genet (2006) 0.75

Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin. Fertil Steril (2006) 0.75

Uterine artery embolization and future fertility potential. Womens Health (Lond Engl) (2007) 0.75

Laparoscopy for investigation of pelvic pain: new approaches? Curr Opin Obstet Gynecol (2003) 0.75